• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
POD-NMD Logo

Pod NMD

  • Who We Are
    • Our Team & Governance
    • Partnerships & Collaborations
  • Resources by Condition
    • Becker Muscular Dystrophy (BMD)
    • Congenital Muscular Dystrophy (CMD)
    • Congenital Myasthenia Syndrome (CMS)
    • Congenital Myopathies (CM)
    • Duchenne Muscular Dystrophy (DMD)
    • General Neuromuscular Diseases (NMD)
    • Glycogen Storage (GSD)
    • Inherited Neuropathies
    • Limb Girdle Muscular Dystrophy (LGMD)
    • Myotonic Dystrophy (DM1)
    • Spinal Muscular Atrophy (SMA)
  • Assessment
    • Motor Performance
    • PROMS
    • Timed Tests
    • Additional Considerations
    • Assessing Babies and Young Children
    • Summary of Function Scales
  • Managing NMD
    • Staying Active & Stretches
    • Managing Other Symptoms
    • Multidisciplinary Care
    • Occupational Therapy
  • CPD Resources
  • Podcasts
    • Duchenne Muscular Dystrophy (DMD)
    • Inherited Neuropathies
    • Limb Girdle Muscular Dystrophy (LGMD)
    • Other
  • Search

Intro to DM1

/ Resources by Condition / Intro to DM1

Introduction to Myotonic Dystrophy Type 1

Myotonic dystrophy (DM) can affect all age groups, and people living with DM1 often have different symptoms at different ranges of severity. DM1 can also affect a range of systems such as brain, heart, endocrine system, eyes and both small and skeletal muscle, so symptom management requires multi-disciplinary care.

  • In its most severe form, it can be present at or shortly after birth.
  • Please note that the mothers and fathers and even grandparents may be affected but undiagnosed at the point of neonatal diagnosis and may need extra support to look after the affected child.
  • Those that present in the neonatal period may have significant respiratory difficulties and poor head control, hypotonia, facial and bulbar weakness which can lead to feeding difficulties.
  • Their low muscle tone does improve with age and despite significant developmental delay responds well to physiotherapy input.
  • Most children will become ambulant by age 5 or 6 although they may need orthotic support and walking aids / wheelchairs for longer distances.
  • Alongside motor delay these children have a facial myopathy with reduced facial expression and a tented shaped mouth which can impact communication speech and lip closure whilst eating.
  • Learning delay is often significant and can result in them being unable to conduct simple respiratory tests such as forced vital capacity.
  • Fatigue is common and pacing is important for this group.

The Myotonic Dystrophy Foundation provides a wealth of information about the extent of  symptoms in Myotonic Dystrophy and how it affects the body.

The MDA also provides information sheets on: Adult Onset DM1, Childhood Onset DM1and Congenital DM1

MDA Myotonic Dystrophy Fact Sheet

Primary Sidebar

  • Becker Muscular Dystrophy (BMD)
    • Intro to BMD
    • Key Management: BMD
    • Key Assessment Guide: BMD
  • Congenital Muscular Dystrophy (CMD)
    • Intro to CMD
    • Key Management: CMD
    • Key Assessment Guide: CMD
  • Congenital Myasthenic Syndromes (CMS)
    • Intro to CMS
    • Key Management: CMS
    • Key Assessment Guide: CMS
  • Congenital Myopathies (CM)
    • Intro to CM
    • Key Management: CM
    • Key Assessment Guide: CM
  • Duchenne Muscular Dystrophy (DMD)
    • Intro to DMD
    • Key Management DMD
    • Key Assessment Guide: DMD
  • General Neuromuscular Diseases (NMD)
    • Intro to NMD
    • Key Management: NMD
    • Key Assessment Guide: NMD
  • Glycogen Storage (GS)
    • Intro to GSD
    • Key Management: GSD
    • Key Assessment Guide: GSD
  • Inherited Neuropathies
    • Intro to Inherited Neuropathies
    • Key Management: Inherited Neuropathies
    • Key Assessment Guide: Inherited Neuropathies
  • Limb Girdle Muscular Dystrophy (LGMD)
    • Intro to LGMD
    • Key Management: LGMD
    • Key Assessment Guide: LGMD
  • Myotonic Dystrophy (DM1)
    • Intro to DM1
    • Key Management: DM1
    • Key Assessment Guide: DM1
  • Spinal Muscular Atrophy (SMA)
    • Intro to SMA
    • Key Management: SMA
    • Key Assessment Guide: SMA

Footer

POD-NMD Logo

Links

Home
Who we are
Resources by condition
Assessment
Managing NMD
CPD Resources
Podcasts

Resources

POD-NMD LMS Login

Contact

Email: podnmd@treat-nmd.org

POD-NMD Privacy Policy POD-NMD LMS Privacy Policy Sitemap © POD-NMD 2026
  • Who We Are
    • Our Team & Governance
    • Partnerships & Collaborations
  • Resources by Condition
    • Becker Muscular Dystrophy (BMD)
      • Intro to BMD
    • Congenital Muscular Dystrophy (CMD)
      • Intro to CMD
      • Key Management: CMD
      • Key Assessment Guide: CMD
    • Congenital Myasthenia Syndrome (CMS)
      • Intro to CMS
      • Key Management: CMS
      • Key Assessment Guide: CMS
    • Congenital Myopathies (CM)
      • Intro to CM
      • Key Management: CM
      • Key Assessment Guide: CM
    • Duchenne Muscular Dystrophy (DMD)
      • Intro to DMD
      • Key Management: DMD
      • Key Assessment Guide: DMD
    • General Neuromuscular Diseases (NMD)
      • Intro to NMD
      • Key Management: NMD
      • Key Assessment Guide: NMD
    • Glycogen Storage (GSD)
      • Intro to GSD
      • Key Management: GSD
      • Key Assessment Guide: GSD
    • Inherited Neuropathies
      • Intro to Inherited Neuropathies
      • Key Management: Inherited Neuropathies
      • Key Assessment Guide: Inherited Neuropathies
    • Limb Girdle Muscular Dystrophy (LGMD)
      • Intro to LGMD
      • Key Management: LGMD
      • Key Assessment Guide: LGMD
    • Myotonic Dystrophy (DM1)
      • Intro to DM1
      • Key Management of DM1
      • Key Assessment Guide: DM1
    • Spinal Muscular Atrophy (SMA)
      • Intro to SMA
      • Key Management: SMA
      • Key Assessment Guide: SMA
  • Assessment
    • Motor Performance
      • NSAA
      • PUL 2.0
      • EK2
      • NSAD
      • RHS
      • HFMSE
      • RULM
      • ATEND
      • CHOP-INTEND
      • MFM
      • GMFM
      • TANS
      • CMS Specific Assessments
      • QMFT
      • GSGC
    • PROMS
      • ACTIVLIM
      • Egen Klassifikation
      • PROM-Upper
      • Myasthenia Gravis
      • Pompe R-PAct
      • Sleepiness
      • Satisfaction with Orthotic Provision
      • QOLgNMD
      • DMD-QoL
    • Timed Tests
      • Timed 10 Metre Walk/Run
      • Timed Rise From Floor
      • 6 Minute Walk Test
      • Timed Up & Go
      • 100 Metre Walk/Run Test
    • Additional Considerations
      • Respiratory Function
      • Pain
      • Posture & Spine
      • Strength
      • Quality of Life
      • Activity and Fatigue
      • Range of Motion
    • Assessing Babies and Young Children
      • Normal/Abnormal Development
      • Developmental Milestones
      • HINE
      • AIMS
      • BSID
      • CHOP-INTEND for Infants
    • Summary of Function Scales
      • Brooke Upper Extremity Grade
      • Vignos Lower Extremity Grade
      • DMDSAT
      • SOFT
  • Managing NMD
    • Staying Active & Stretches
      • Staying Active
      • Stretches
      • Jaw Tightness (Trismus)
      • Scoliosis Management
    • Managing Other Symptoms
      • Falls Management
      • Fatigue Management
      • Pain Management
      • Respiratory Management
      • Continence Care
      • Oedema Management
    • Multidisciplinary Care
      • Orthopaedic Management
      • Additional Multidisciplinary Management
      • Orthotics
      • Equipment Ideas
    • Occupational Therapy
      • Overview of Role
      • Home Adjustments
      • Mobility Aids and Wheelchairs
      • Support for Sitting
      • Mobile Arm Supports
      • Robotics
  • CPD Resources
  • Podcasts
    • Duchenne Muscular Dystrophy (DMD)
    • Inherited Neuropathies
    • Limb Girdle Muscular Dystrophy (LGMD)
    • Other
  • Search